stockrow
Friday 6 November 2026
Export CNMD’s income statement to Excel — free account
CONMED Corporation
CNMD Healthcare Medical Devices
CONMED Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 5.18% from fiscal 2024.
- Revenue
- −0.70%
- EPS
- +635.0%
- Free cash flow
- −3.65%
- Total debt
- −4.44%
Quarter to September 2026, against a year earlier
51.50
1.33
−2.52%
Follow CNMD
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 6 | 6 | 8 |
| 4.72% | 5.50% | 5.53% | 7.10% | ||
| 2.03% | 2.38% | 2.44% | 3.17% | ||
ROIC |
3.51% | 3.80% | 3.75% | 4.64% | |
Return on Tangible Assets |
9.99% | 11.20% | 17.10% | 22.13% | |
Average Days of Receivables |
65.80 | 60.90 | 63.80 | 62.35 | |
Free Cash Flow per Share |
4.86 | 4.04 | 4.47 | 4.43 | |
Free Cash Flow |
150.88 | 123.71 | 134.46 | 132.69 | |
Capital Expenditures |
(19.81) | (18.92) | (16.12) | (13.62) | |
| Other line items | |||||
Cash ROIC |
7.90% | 6.46% | 7.03% | 6.90% | |
Accounts Receivable Turnover |
5.66 | 6.09 | 5.79 | 5.97 | |
Accounts Payable Turnover |
6.37 | 6.11 | 6.00 | 5.65 | |
Inventory Turnover |
1.78 | 1.70 | 1.68 | 1.60 | |
Average Days of Payables |
54.76 | 62.63 | 60.81 | 61.88 | |
Days of Inventory on Hand |
207.89 | 217.51 | 216.81 | 227.96 | |
Tax Rate |
(0.34) | (0.33) | (0.32) | (0.30) | |
Research and Development Expense of Revenue |
4.07% | 4.32% | 4.42% | 4.55% | |
Selling, General and Administrative Expense of Revenue |
43.06% | 42.67% | 43.33% | 43.12% | |
Share Based Compensation of Revenue |
2.06% | 1.46% | 1.48% | 1.58% | |
Interest Coverage |
3.30 | 3.75 | 3.69 | 4.05 | |
Operating CF/Net income |
3.63 | 2.60 | 2.67 | 1.99 | |
Depreciation/Fixed assets |
0.71 | 0.72 | 0.73 | 0.74 | |
Capex/Depreciation |
(0.25) | (0.24) | (0.20) | (0.17) | |
Revenue per Share |
44.29 | 44.81 | 45.62 | 45.76 | |
Operating CF per Share |
5.50 | 4.66 | 5.01 | 4.89 | |
Capex per Share |
(0.64) | (0.62) | (0.54) | (0.46) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 2 Nov 2026